| Date Filed | Type | Description |
| 03/06/2023 |
4
| Knappertz Volker (EVP, Research and Development) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Granted 191,462 shares
@ $0 |
|
| 08/01/2022 |
4
| Knappertz Volker (EVP, Research and Development) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Granted 256,892 options to buy
@ $8.18, valued at
$2.1M
Granted 152,812 restricted stock units
@ $0 |
|
| 07/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 12,000 shares
@ $10.5, valued at
$126k
|
|
| 11/13/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 6,000 shares
@ $10, valued at
$60k
|
|
| 11/05/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 6,000 shares
@ $9.17, valued at
$55k
|
|
| 08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 4,296 shares
@ $14.63, valued at
$62.9k
Sold 18,000 shares
@ $10.35, valued at
$186.3k
|
|
| 06/08/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Granted 155,028 options to buy
@ $0
Granted 93,024 options to buy
@ $0 |
|
| 05/20/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 121,476 shares
@ $0.0012, valued at
$145.8
Paid exercise price by delivering 5,868 shares
@ $9.67, valued at
$56.7k
Exercised 12,144 shares
@ $0.0012, valued at
$14.6
Exercised 121,476 options
@ $0
Exercised 12,144 options
@ $0 |
|
| 03/04/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 3,420 shares
@ $8.32, valued at
$28.5k
|
|
| 02/28/2020 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 2,832 shares
@ $9.17, valued at
$26k
Sold 180 shares
@ $9.26, valued at
$1.7k
|
|
| 05/21/2019 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 12,144 shares
@ $0.0013, valued at
$15.8
Sold 5,832 shares
@ $14.52, valued at
$84.7k
Sold 6,312 shares
@ $14.76, valued at
$93.2k
Exercised 12,144 options to buy
@ $0 |
|
| 03/05/2019 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 3,732 shares
@ $14.46, valued at
$54k
Granted 48,252 options to buy
@ $0
Granted 91,584 options to buy
@ $0
Granted 6,864 options to buy
@ $0 |
|
| 02/28/2019 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 8,436 shares
@ $0.0013, valued at
$11
Sold 504 shares
@ $12.44, valued at
$6.3k
Sold 3,600 shares
@ $12.46, valued at
$44.9k
Sold 36 shares
@ $12.29, valued at
$442.4
Exercised 8,436 options
@ $0 |
|
| 10/01/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |